Clinical ResearchResearch compound

Yohimbine

α2-adrenoceptor antagonist (Pausinystalia yohimbe), used as a supplement to mobilize "stubborn fat" depots.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Yohimbine vial

WHAT IS YOHIMBINE?

Detailed overview

Yohimbine is an indole alkaloid isolated from the bark of the West African Yohimbe tree (Pausinystalia yohimbe). Its mechanism is selective α2-adrenoceptor antagonism: α2 blockade inhibits the anti-lipolytic feedback loop and raises noradrenaline release in adipose tissue. α2 receptor density is high in abdominal and femoral "stubborn fat" depots, so Yohimbine is theoretically selectively effective in these areas. In the US it is an OTC dietary supplement; in the EU regulatory status varies by country. It was clinically used for erectile dysfunction (Yocon), but efficacy is debated in the post-2010 PDE5-inhibitor era.

Mechanism

α2-adrenoceptor antagonist

Half-life

0.6-2 hours (short)

Onset

30-45 min

Legal status

USA: OTC supplement. EU: mixed (HU: prescription). WADA: not listed.

Data console

Lab data

/lab/molecular-data.jsonLIVE
> Androgenic:Anabolic-
> AR bindingN/A
> Active half-life0.6-2 h
> Detection windowN/A
> AromatizationNot applicable – indole alkaloid α2-antagonist, NOT a steroid; no CYP19 interaction
> HepatotoxicityLow – anxiogenic and cardiovascular risk dominates (tachycardia, hypertension); rare hepatotoxicity only at overdose (NIH LiverTox 2024)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Anxiety, nervousness, panic attacks and inner tremor – the most common, dose-dependent effect from increased noradrenaline release via central α2 blockade.
  • Raised blood pressure and risk of hypertensive crisis, especially combined with MAOIs or tyramine-rich foods.
  • Tachycardia, palpitations and arrhythmias; rarely angina or myocardial infarction in overdose.
  • Insomnia and restlessness, especially with afternoon/evening dosing – CNS stimulation outlasts the short half-life.
  • Nausea, abdominal discomfort and vomiting, more common at high doses (>0.4 mg/kg).
  • Headache, dizziness, sweating and flushing from sympathomimetic activation.
  • Increased urinary frequency and urine output (inhibition of antidiuretic signalling).
  • Product-quality risk: many commercial yohimbine supplements are mislabelled with 0–12 mg/serving variance (Cohen 2015), causing unpredictable overdose.

Contraindications · 7

  • Chronic clonidine (or other α2-agonist) use: direct pharmacological conflict, documented intracranial haemorrhage after a single dose (Pham 2022) – absolute contraindication.
  • Concurrent MAOI, SSRI or tricyclic antidepressant use – risk of hypertensive crisis and serotonergic/adrenergic overload.
  • Serious cardiovascular disease: uncontrolled hypertension, coronary artery disease, arrhythmia or prior myocardial infarction.
  • Anxiety disorder, panic disorder or PTSD – α2 antagonism provokes panic attacks and anxiety.
  • Pregnancy and breastfeeding – oxytocin-like uterotonic effect and teratogenic uncertainty.
  • Severe kidney or liver disease – reduced CYP2D6 clearance leads to accumulation and increased toxicity.
  • Benign prostatic hyperplasia (BPH) – may worsen urinary symptoms.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Yohimbine?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.